(Q35555122)

8 August 2017

title

Tissue-type plasminogen activator: characteristics, applications and production technology (English)

1 reference

8 August 2017

Tissue-type plasminogen activator: Characteristics, applications and production technology (English)

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

19 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

19 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

Applied Microbiology and Biotechnology

19 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

19 March 2024

3

Y. Chisti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14537155

19 March 2024

author name string

S. A. Rouf

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14537155

19 March 2024

M. Moo-Young

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14537155

19 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14537155

19 March 2024

publication date

1 January 1996

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:0734975096000195?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

https://api.elsevier.com/content/article/PII:0734975096000195?httpAccept=text/plain

19 March 2024

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

19 March 2024

published in

Biotechnology Advances

1 reference

8 August 2017

volume

14

1 reference

8 August 2017

issue

3

1 reference

8 August 2017

page(s)

239-266

1 reference

Isolation and purification of a tissue plasminogen activator and its comparison with urokinase

8 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

19 March 2024

plasminogen activator

2

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

Isolation of two variants of native one-chain tissue plasminogen activator

19 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

Process economics of animal cell and bacterial fermentations: a case study analysis of tissue plasminogen activator

19 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

Tissue plasminogen activator: peptide analyses confirm an indirectly derived amino acid sequence, identify the active site serine residue, establish glycosylation sites, and localize variant differences

19 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

The fibrinolytic activity of human tissues

19 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

Purification and properties of plasminogen activators from epithelial cells.

19 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

Animal cell culture in stirred bioreactors: Observations on scale-up

19 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

Human tissue-type plasminogen activator. Production in continuous serum-free cell culture and rapid purification

19 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

Large-scale purification of human tissue-type plasminogen activator using monoclonal antibodies

19 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

Purification and characterization of a melanoma cell plasminogen activator

19 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

Expression of active human uterine tissue plasminogen activator in yeast

19 March 2024

39

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

Purification and identification of two structural variants of porcine tissue plasminogen activator by affinity adsorption on fibrin

19 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

Purification of plasminogen activator from Rous sarcoma virus-infected chick embryo fibroblast culture medium.

19 March 2024

51

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

Immunoaffinity purification of tissue plasminogen activator from serum-supplemented conditioned media using monoclonal antibody

19 March 2024

52

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

Synthesis and Purification of Active Human Tissue Plasminogen Activator From Escherichia coli

19 March 2024

58

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

Purification and production of therapeutic grade proteins

19 March 2024

61

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

Treatment with stanozolol before thrombolysis in patients with arterial occlusions

19 March 2024

64

1 reference

https://api.crossref.org/works/10.1016/0734-9750(96)00019-5

19 March 2024

Identifiers

1 reference

8 August 2017

1 reference